Skip to main content
Tiffany Braley, MD, Neurology, Ann Arbor, MI, University of Michigan Medical Center

TiffanyBraleyMDMS

Neurology Ann Arbor, MI

Neuroimmunology/Multiple Sclerosis

Director, Multiple Sclerosis and Clinical Neuroimmunology Division, Department of Neurology, Michigan Medicine

Dr. Braley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Braley's full profile

Already have an account?

Education & Training

  • University of Michigan School of Public Health
    University of Michigan School of Public HealthM.S., Clinical Research Design and Statistical Analysis, 2009 - 2011
  • University of Michigan Health System
    University of Michigan Health SystemFellowship, Neuroimmunology & Multiple Sclerosis, 2008 - 2011
  • University of Michigan Health System
    University of Michigan Health SystemResidency, Neurology, 2005 - 2008
  • St Joseph Mercy Ann Arbor
    St Joseph Mercy Ann ArborInternship, Internal Medicine, 2004 - 2005
  • Wayne State University School of Medicine
    Wayne State University School of MedicineClass of 2004

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2008 - 2024
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Holtom-Garrett Family Professor of Neurology University of Michigan
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Life’s Stressors Linked to Health Decline in Multiple Sclerosis Patients
    Life’s Stressors Linked to Health Decline in Multiple Sclerosis PatientsMay 24th, 2023
  • Insomnia, Sleep Apnea Rise in Women with MS
    Insomnia, Sleep Apnea Rise in Women with MSMarch 27th, 2023
  • Sleep Disorders Linked to Cognitive Decline in MS
    Sleep Disorders Linked to Cognitive Decline in MSMarch 23rd, 2023
  • Join now to see all

Grant Support

  • Mechanisms of cannabidiol in persons with MS: The role of sleep and pain phenotypeNIH/NCCIH2021–2026
  • Pathways between OSA and cognitive decline in older women and men: a longitudinal population-based studyNIH/NIA2021–2025
  • A randomized controlled trial of telephone-delivered COgnitive behavioral-therapy, Modafinil, and combination therapy of BOth interventions for fatigue in MS (“COMBO-MS”)Patient-Centered Outcomes Research Institute2018–2022
  • A randomized trial of positive airway pressure therapy to treat cognitive dysfunction in MS patients with obstructive sleep apneaNational Multiple Sclerosis Society2015–2020
  • Recognition and treatment of obstructive sleep apnea among Medicare beneficiariesAmerican Sleep Medicine Foundation2015–2019
  • Dimethyl fumarate: a novel therapeutic agent for obstructive sleep apneaUniversity of Michigan Medical School’s Michigan Translation and Commercialization (MTRAC) for Life Sciences Program2015–2016

Professional Memberships

Hospital Affiliations